Am Fam Physician. 2025;112(1):96
CLINICAL QUESTION
Is bright light therapy effective treatment for adults with non-seasonal depressive disorders?
BOTTOM LINE
This updated meta-analysis of 11 individual trials published since 2000 found evidence to support the benefit of bright light therapy as an effective treatment or adjunctive treatment for adults with nonseasonal depressive disorders. (Level of Evidence = 1a)
SYNOPSIS
Investigators searched multiple databases, including Medline, EMBASE, SCOPUS, Web of Science, PsychINFO, and the Cochrane database, for English language–only randomized trials that compared bright light therapy alone or bright light therapy plus an antidepressant with placebo, antidepressant monotherapy, or dim red light in adults with nonseasonal depression. Bright light therapy was defined as using a fluorescent light box that produces 10,000 lux of white light for at least 30 minutes daily. Two people independently assessed individual trials for inclusion criteria and risk of bias using the Cochrane Risk of Bias tool. Disagreements were resolved by consensus discussion with a third reviewer. All 11 trials (N = 858) that met inclusion criteria were scored at low risk of bias.
Subscribe
From $180- Immediate, unlimited access to all AFP content
- More than 125 CME credits/year
- AAFP app access
- Print delivery available
Issue Access
$59.95- Immediate, unlimited access to this issue's content
- CME credits
- AAFP app access
- Print delivery available